CARBIDOPA AND LEVODOPA
- Product NDC
- 47335-186
- 11-digit product format
- 473350186
- Labeler code
- 47335
- Product ID
- 47335-186_5c297458-6e97-4222-8a82-1b28928ce796
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBIDOPA AND LEVODOPA
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA078690
- Marketing category
- ANDA
- Marketing start
- 2014-12-15
- Substance
- CARBIDOPA; LEVODOPA
- Active strength
- 10; 100 mg/1; mg/1
- Pharmacologic classes
- Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CARBIDOPA AND LEVODOPA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARBIDOPA | 10 mg/1 |
| LEVODOPA | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MNX7R8C5VO, 46627O600J |
| Rxcui | 476399, 476515, 483090 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 47335-186-08 | CARBIDOPA AND LEVODOPA | 100 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 100 | | 8 |
| 47335-186-18 | CARBIDOPA AND LEVODOPA | 1000 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 1000 | | 8 |
| 47335-186-83 | CARBIDOPA AND LEVODOPA | 30 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 30 | | 8 |
| 47335-186-88 | CARBIDOPA AND LEVODOPA | 100 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 100 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CARBIDOPA | ACTIVE INGREDIENT | MNX7R8C5VO | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| LEVODOPA | ACTIVE INGREDIENT | 46627O600J | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| CARBIDOPA ANHYDROUS | ACTIVE MOIETY | KR87B45RGH | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| LEVODOPA | ACTIVE MOIETY | 46627O600J | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| CALCIUM SILICATE | INACTIVE INGREDIENT | S4255P4G5M | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMA GLOBAL FZE] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47335-186 | CARBIDOPA AND LEVODOPA TABLET, ORALLY DISINTEGRATING [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 8 | Current NDC, Legacy NDC, 4 package rows | 20241210_48e0f2ec-b217-4c25-a71c-20e173d05edb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47335-186-08 | 47335018608 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-08) | 2014-12-15 | 0000-00-00 | No | No | Current |
| 47335-186-18 | 47335018618 | 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-18) | 2014-12-15 | 0000-00-00 | No | No | Current |
| 47335-186-83 | 47335018683 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-83) | 2014-12-15 | 0000-00-00 | No | No | Current |
| 47335-186-88 | 47335018688 | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (47335-186-88) | 2014-12-15 | 0000-00-00 | No | No | Current |